Pharmacological characterization of the discriminative stimulus effects of the potassium channel blocker 4-aminopyridine in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 1, 2000, Pages 382-391

  Brandsgaard, R ^a   Barrett, J E ^a   Rosenzweig Lipson, S ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (1 METHYL 5 INDOLYL) 3 (3 PYRIDYL)UREA; 1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 2 AMINO 4 PHOSPHONOBUTYRIC ACID; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,6 DIAMINOPYRIDINE; 3 AMINOPYRIDINE; 3,4 DIAMINOPYRIDINE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 4 DIMETHYLAMINOPYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; CLOZAPINE; DIAZEPAM; DOPAMINE; HALOPERIDOL; IMIPRAMINE; KETANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N METHYL DEXTRO ASPARTIC ACID; NISOXETINE; NORADRENALIN; PROPRANOLOL; PYRIDINE; PYRIDINE DERIVATIVE; SEROTONIN; TOMOXETINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE;

ANIMAL EXPERIMENT; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG ANTAGONISM; DRUG DISCRIMINATION; MALE; NEUROPHARMACOLOGY; NONHUMAN; POTASSIUM CHANNEL; PRIORITY JOURNAL; RAT;

4-AMINOPYRIDINE; ANIMAL; CHOLINERGIC AGENTS; DISCRIMINATION LEARNING; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; MALE; PINACIDIL; POTASSIUM CHANNEL BLOCKERS; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGENTS;

EID: 0033803402     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Behavioral effects of the potassium channel blocker 4-aminopyridine and its structural analogs
2. Cholinergic agents and delay-dependent performance in the rat
3. The pharmacology of potassium channels and their therapeutic potential
4. Kainic acid and 4-aminopyridine seizure models in mice: Evaluation of efficacy of anti-epileptic agents and calcium antagonists
5. Differential effects of 4-aminopyridine and 2,4-diaminopyridine on the in vivo release of acetylcholine and dopamine in freely moving rats measured by intrastriatal dialysis
6. Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats
7. Stimulus properties of the L-type calcium channel agonist BAY K 8644 in rats
8. 2+ imaging
9. Effects of chlordiazepoxide training dose on the mixed agonist-antagonist properties of benzodiazepine receptor antagonist Ro 15-1788, in a drug discrimination procedure
10. +-channels
11. Specificity of tetraethylammonium and quinine for three K channels in insulin-secreting cells
12. Linopiridine (DuP 996) improves performance in several tests of learning and memory by modulation of cholinergic neurotransmission
13. NMDA receptor antagonists protect against seizures and wet-dog shakes induced by 4-aminopyridine
14. Preliminary analysis of the discriminative stimulus induced by the calcium channel agonist BAY K 8644
15. The aminopyridines
16. 5-HT(2A) receptor involvement in the effects of the potassium channel blocker 4-aminopyridine
17. + channels, types Kv1.1, 1.2, 1.5, and 3.1, stably expressed in mammalian cell lines
18. + channels in substantia nigra
19. 2+ sensitivity and presynaptic control
20. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro
21. + channel-blocking scorpion venom peptide toxins tityustoxin-Kα and pandinustoxin-Kα
22. Pinacidil opens the ATP-sensitive and Ca-dependent K channel in smooth muscle cells of the rat and rabbit portal veins
23. 3,4-Diaminopyridine: A potent new potassium channel blocker
24. Antagonism of xylazine sedation by 4-aminopyridine and yohimbine in cattle
25. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents
26. Quinine and 4-aminopyridine inhibit the stimulatory output of dopamine in nucleus accumbens and the behavioural activity produced by morphine
27. 3 agonist quinpirole in monkeys
28. Attenuation of the behavioral effects of anxiolytics by the K-channel blocker 4-aminopyridine
29. Attenuation of the locomotor activating effects of d-amphetamine, cocaine, and scopolamine by potassium channel modulators
30. Modification of the behavioral effects of d-fenfluramine and mCPP by SB-200646
31. Diversity and ubiquity of K channels
32. 3H]5-hydroxytryptamine in rat hippocampal slices
33. 3H]dopamine from rat brain synaptosomes
34. Characterization of 4-aminopyridine in overdose
35. Antagonism of the rate-decreasing effects of 8-OH-DPAT in rats by 5-HT1A compounds varying in intrinsic activity
36. Antidepressant-like effects of potassium channel blockers
37. 4-Aminopyridine differentially affects the spontaneous release of radiolabelled transmitters from rat brain slices in vitro
38. Function and structure of voltage-dependent potassium channels
39. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats
40. Dynamics of aminopyridine block of potassium channels in squid axon membrane
41. Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats